Al-Sense panty liner device
This article was originally published in The Tan Sheet
Executive Summary
Barr Pharmaceuticals subsidiary Duramed Pharmaceuticals has signed an agreement with Common Sense to develop Al-Sense, a panty liner that detects amniotic fluid. The medical device features a proprietary polymer-coated polyester strip designed to detect amniotic fluid, which could indicate a problem with a pregnancy. The parties are seeking approval of the device in the U.S. and Canada. Although the product would only be available by prescription, other firms have demonstrated an interest in using panty liners as a product delivery form. Fem-V recently announced the launch of its liner, which allows women to test for vaginal infection from their homes by measuring the pH level in vaginal discharge ("1The Tan Sheet" July 3, 2006, p. 10)...
You may also be interested in...
NACDS In Brief
Aleve liqui-gels: Bayer's launch of Aleve liqui-gels demonstrates the growing popularity of the formulation on the market. The product, which contains naproxen sodium 220 mg, will make its marketplace debut in 20-, 40- and 80-count packages in January 2007, the firm announces at the National Association of Chain Drugstores Marketplace conference and tradeshow in San Diego, Calif. June 24-27. A TV and print ad campaign will support the launch, Bayer says. Aleve currently is available in tablets, caplets and gelcaps. Wyeth's Advil liqui-gels saw a 25% sales increased in early 2005, despite concerns about NSAID use (1"The Tan Sheet" July 25, 2005, p. 5)...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.